Tobias J. Grob - Publications

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Journal: The oncologist

Published: February 13, 2026

Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.

Journal: British journal of cancer

Published: October 31, 2025

In Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy, Dynamics of Circulating Tumor DNA Following Cystectomy: Association with Patient Outcomes.

Journal: European urology focus

Published: November 08, 2024

Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.

Journal: Virchows Archiv : an international journal of pathology

Published: August 07, 2024

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.

Journal: Case reports in oncology

Published: September 04, 2023

Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.

Journal: Virchows Archiv : an international journal of pathology

Published: August 18, 2023

Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.

Journal: NPJ precision oncology

Published: June 13, 2023

Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer.

Journal: Case reports in oncology

Published: May 25, 2023

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma.

Journal: JCO precision oncology

Published: February 08, 2023

Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions.

Journal: Scientific reports

Published: August 31, 2022

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.

Journal: Journal of cancer research and clinical oncology

Published: June 26, 2017

Recurrent multilocular mandibular giant cell granuloma in neurofibromatosis type 1: Evidence for second hit mutation of NF1 gene in the jaw lesion and treatment with curettage and bone substitute materials.

Journal: Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery

Published: March 25, 2016

‌

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Liquid biopsy-based detection of acquired MET resistance enables sequential targeted therapy in MET fusion-positive NSCLC.

Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.

Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costing.

In Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy, Dynamics of Circulating Tumor DNA Following Cystectomy: Association with Patient Outcomes.

In Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy, Dynamics of Circulating Tumor DNA Following Cystectomy: Association with Patient Outcomes.

Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.

Reporting of somatic variants in clinical cancer care: recommendations of the Swiss Society of Molecular Pathology.

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.

Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report.

Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.

Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.

Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.

Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies.

Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer.

Complete Response on Larotrectinib in NTRK2 Fusion-Positive Non-Small Cell Lung Cancer.

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma.

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma.

Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions.

Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions.

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.

Prevalence of fibroblast growth factor receptor 1 (FGFR1) amplification in squamous cell carcinomas of the head and neck.

Recurrent multilocular mandibular giant cell granuloma in neurofibromatosis type 1: Evidence for second hit mutation of NF1 gene in the jaw lesion and treatment with curettage and bone substitute materials.

Recurrent multilocular mandibular giant cell granuloma in neurofibromatosis type 1: Evidence for second hit mutation of NF1 gene in the jaw lesion and treatment with curettage and bone substitute materials.